Abacavir And Lamivudine Tablet, Film Coated
Product Images NDC 65862-335

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Abacavir And Lamivudine (NDC 65862-335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel – 600 mg/300 mg (30 Tablets Container) (Abalami Fig1)

Packaging label for Abacavir and Lamivudine Tablets USP containing 600 mg and 300 mg respectively in film-coated tablet form. The label states it is for Rx only and is distributed by Aurobindo Pharma USA, Inc. It includes storage instructions and a notice to dispensers about providing a Medication Guide and Warning Card. The package contains 30 tablets and is made in India by Aurobindo Pharma Limited.*

FDA Label Image

Package Label-principal Display Panel – 600 mg/300 mg (30 Tablets Container Carton) (Abalami Fig2)

Packaging label for Abacavir and Lamivudine Tablets USP 600 mg / 300 mg film-coated tablets. The label includes NDC 65862-335-30 and states the product is for Rx only, with a package size of 30 tablets. It is distributed by Aurobindo Pharma USA, Inc. and made in India. The label also includes a caution notice for authorized dispensers to provide a Medication Guide and Warning Card with each dispensed container.*

FDA Label Image

Package Label-principal Display Panel – 600 mg/300 mg (100 Unit-dose Tablets (10 X 10s)) (Abalami Fig3)

Packaging label for Abacavir and Lamivudine Tablets USP, 600 mg / 300 mg film-coated tablets. The label indicates a package size of 100 unit-dose tablets (10 x 10s) and includes the NDC 65862-335-10. The product is distributed by Aurobindo Pharma USA, Inc., and made in India. The label contains dosing information and a notice to authorized dispensers to provide a Medication Guide and Warning Card with each dispensed product.*

FDA Label Image

Abacavir Sulfate Structure (Abalami Str1)

Chemical structure diagram showing the molecular composition of abacavir and lamivudine as indicated by the product data. The image depicts two repeated units of the compound including ring structures and functional groups, along with a sulfate component noted as -H2SO4.*

FDA Label Image

Lamivudine Structure (Abalami Str2)

Chemical structure of the active ingredient abacavir, showing its molecular arrangement with heterocyclic nitrogen atoms and hydroxyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.